Literature DB >> 6324001

Nucleotide sequence of mutant I-A beta bm12 gene is evidence for genetic exchange between mouse immune response genes.

K R McIntyre, J G Seidman.   

Abstract

Immune response genes of the murine major histocompatibility complex encode cell-surface glycoproteins that are expressed predominantly on B cells and macrophages and regulate immune responsiveness by restricting antigen recognition by T cells. The two classes of immune response molecule, termed I-A and I-E, are each comprised of two polymorphic chains (alpha and beta), and nucleotide sequence analysis of genomic or cDNA clones has revealed that most of the amino acid differences between allelic I-A alpha or beta chains occur in the first extracellular domain. The mutant mouse strain B6.C-H-2bm12 (bm12), which differs from its parental strain C57BL/6 (B6) at the I-A beta locus, exhibits an immune response profile markedly different from that of B6. Here we present the nucleotide sequence of the mutant bm12 I-A beta gene. Sequence comparison within the coding regions reveals three productive nucleotide differences between the I-A beta genes of B6 and bm12 mice, all three differences occurring within a stretch of 14 nucleotides in the exon encoding the first extracellular domain. The clustered nature of the bm12 mutation, as well as the specific amino acid changes it engenders, suggest a possible mechanism for the generation of polymorphism in class II antigens.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6324001     DOI: 10.1038/308551a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  60 in total

1.  Specificity of CD4+CD25+ regulatory T cell function in alloimmunity.

Authors:  Alberto Sánchez-Fueyo; Sigrid Sandner; Antje Habicht; Christophe Mariat; James Kenny; Nicolas Degauque; Xin Xiao Zheng; Terry B Strom; Laurence A Turka; Mohamed H Sayegh
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

2.  Identification of functional regions on the I-Ab molecule by site-directed mutagenesis.

Authors:  L E Cohn; L H Glimcher; R A Waldmann; J A Smith; A Ben-Nun; J G Seidman; E Choi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

3.  Molecular analysis of antigen recognition by insulin-specific T-cell hybridomas from B6 wild-type and bm12 mutant mice.

Authors:  D H Sherman; P S Hochman; R Dick; R Tizard; K L Ramachandran; R A Flavell; B T Huber
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

Review 4.  Antigen-major histocompatibility complex-T cell receptors: inquiries into the immunological ménage à trois.

Authors:  J Klein
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

5.  Biology of the human histocompatibility leukocyte antigen (HLA) system and a hypothesis regarding the generation of autoimmune diseases.

Authors:  J L Strominger
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

6.  Allogeneic substitution for nominal antigen-specific T-cell clone reactivity in schistosomiasis.

Authors:  G P Linette; P J Lammie; S M Phillips
Journal:  Immunology       Date:  1986-04       Impact factor: 7.397

7.  Allogeneic T regulatory cell-mediated transplantation tolerance in adoptive therapy depends on dominant peripheral suppression and central tolerance.

Authors:  Dennis Adeegbe; Robert B Levy; Thomas R Malek
Journal:  Blood       Date:  2009-12-29       Impact factor: 22.113

8.  A molecular basis for the Ia.2 and Ia.19 antigenic determinants.

Authors:  D Landais; H Matthes; C Benoist; D Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

9.  A biochemical analysis of Ak molecules from mutant antigen presenting cell lines.

Authors:  S Chatterjee-Das; G G Schlauder; D H Sachs; L H Glimcher; W E Paul; D J McKean
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

10.  How many class II immune response genes? A reappraisal of the evidence.

Authors:  E Simpson; R Lieberman; I Andó; D H Sachs; W E Paul; J A Berzofsky
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.